Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stevanato Group S.p.A (STVN) Asset Utilization Ratio (2021 - 2026)

Stevanato Group S.p.A (STVN) reported Asset Utilization Ratio of 0.47 for Q1 2026, down 4.82% year-over-year from 0.49 in Q1 2025, and little changed on a QoQ basis from 0.47 in Q4 2025.

Stevanato Group S.p.A (STVN) has 6 years of Asset Utilization Ratio data on file, last reported at 0.47 in Q1 2026.

  • Quarterly Asset Utilization Ratio fell 4.82% year-over-year to 0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.47 (down 4.82% YoY) and the FY2025 annual result came in at 0.51, up 1.32% from the prior year.
  • Asset Utilization Ratio steadied at 0.47 in Q1 2026 per STVN's latest filing, from 0.47 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.62 in Q4 2022 and bottomed at 0.47 in Q4 2025.
  • The 5-year median for Asset Utilization Ratio is 0.51 (2024), against an average of 0.53.
  • The widest annual swing landed in 2022, when Asset Utilization Ratio increased 1.24%; it then decreased 13.98% in 2024.
  • Tracing STVN's Asset Utilization Ratio over 5 years: stood at 0.62 in 2022, then slipped by 12.43% to 0.54 in 2023, then decreased by 10.52% to 0.49 in 2024, then slipped by 4.23% to 0.47 in 2025, then climbed by 0.23% to 0.47 in 2026.
  • Per Business Quant, the three latest STVN Asset Utilization Ratio figures stand at 0.47 (Q1 2026), 0.47 (Q4 2025), and 0.47 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.52
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.40
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.64
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.77
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.58
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.33
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.65
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.54
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.75
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn 0.47

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.47
Dec 31, 2025 0.47
Sep 30, 2025 0.47
Jun 30, 2025 0.49
Mar 31, 2025 0.49
Dec 31, 2024 0.49
Sep 30, 2024 0.49
Jun 30, 2024 0.49
Mar 31, 2024 0.51
Dec 31, 2023 0.54
Sep 30, 2023 0.55
Jun 30, 2023 0.56
Mar 31, 2023 0.59
Dec 31, 2022 0.62
Sep 30, 2022 0.61
Jun 30, 2022 0.61
Mar 31, 2022 0.61
Dec 31, 2021 0.61
Sep 30, 2021 0.69